The Quantellect read.As of Nov 19, 2026, 3 active firms cover TriSalus Life Sciences Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $7.00 to $12.00, a moderate spread. The average target of $9.00 sits 268% above the current $2.44. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.10 next quarter toward $-0.47 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$9.00
+268.1% upside
Average target across 3 active firms as of Nov 19, 2026 vs $2.45 current
Highest Target$12.00
Average Target$9.00
Lowest Target$7.00
Detailed analyst forecasts for TLSI
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate TLSI a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TLSI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.10
Range $-0.12 – $-0.09 · 3 analysts
Next period, 3 analysts expect TriSalus Life Sciences Inc. to earn $-0.10 a share (range $-0.12 – $-0.09), versus — a year earlier. Full-year consensus is $-0.43, growing to $-0.47 the year after.
REVENUE · NEXT QUARTER
$16.9M
Range $14.9M – $18.8M · 3 analysts
Revenue is expected to reach $16.9M (range $14.9M – $18.8M). Full-year consensus is $46.7M, rising to $59.5M next year.
Top analysts covering TriSalus Life Sciences Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TLSI.
#1
Ross Osborn
Cantor Fitzgerald · Rank #238
Buy
$9.00+268.1% to target
Overall win rate
34%
+ Follow
#2
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$12.00+390.8% to target
Overall win rate
38%
+ Follow
#3
William Plovanic
Canaccord Genuity · Rank #370
Buy
$7.00+186.3% to target
Overall win rate
38%
+ Follow
#4
JW
Jason Wittes
Roth MKM · Rank #382
Buy
$11.00+349.9% to target
Overall win rate
40%
+ Follow
#5
Frank Takkinen
Lake Street · Rank #514
Buy
$8.00+227.2% to target
Overall win rate
27%
+ Follow
TLSI stock forecast FAQ
What is TLSI's average 12-month price target?+
The 3 active firms with a live target average $9.00 for TriSalus Life Sciences Inc. over the next 12 months, ranging from a $12.00 high to a $7.00 low, as of Nov 19, 2026.
Is TLSI stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for TLSI?+
The Street-high target is $12.00 (HC Wainwright & Co.), and the Street-low is $7.00 (Canaccord Genuity). The average of all 3 active-firm targets is $9.00.
How many active Wall Street firms cover TLSI?+
3 active firms have a recognized rating on TriSalus Life Sciences Inc. as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TLSI?+
Among analysts who currently cover TLSI, Ross Osborn of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $9.00 target.
What is TriSalus Life Sciences Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.10 per share (range $-0.12 – $-0.09) across 3 analysts. Full-year EPS is projected at $-0.43, rising to $-0.47 the following year.
How much revenue is TriSalus Life Sciences Inc. expected to report next quarter?+
Consensus revenue is $16.9M (range $14.9M – $18.8M). Full-year revenue is projected at $46.7M, growing to $59.5M next year.
Have analysts been upgrading or downgrading TLSI lately?+
As of Nov 19, 2026, 3 of 3 active firms rate TLSI a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TLSI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.